Statistical Calculators › Means: One and Two Groups › Mann-Whitney U Test Sample Size (Non-Parametric)
← All Calculators

Means: One and Two Groups

Mann-Whitney U Test Sample Size (Non-Parametric)

Sample size planning for a two-group Mann-Whitney U (Wilcoxon rank-sum) test using the Noether approximation for continuous outcomes without ties. Specify the competing probability, power, significance level, and allocation ratio; the calculator finds the smallest integer group sizes that meet the target power.

Study Design

The effect size is the probability that a randomly selected observation from Group 1 is at least as large as one from Group 2.

Sample Size

Uses the Noether large-sample approximation and then searches integer group sizes to meet the requested power.
Enter the study parameters and click Calculate Sample Size.

Methodology

The calculator uses the Noether (1987) approximation for the two-sample Mann-Whitney U / Wilcoxon rank-sum test. This method uses this procedure for continuous data without ties and defines the effect size as the competing probability P1 = P(Y1 ≥ Y2). Under the null hypothesis, P1 = 0.5.

Sample Size Formula

Let N = N1 + N2 be the total evaluable sample size and let c = N1/N. For a two-sided test, the Noether approximation is:

N = [z1-α/2 + zpower]2 / [12 c(1-c)(P1 - 0.5)2]

For a one-sided test, z1-α/2 is replaced by z1-α. Because actual group sizes must be integers, the calculator evaluates candidate integer group sizes near the continuous solution and reports the smallest design that achieves at least the requested power under the same approximation.

Allocation Ratio

The allocation ratio is entered as R = N2/N1. Equal allocation corresponds to R = 1. For an unequal allocation, the calculator searches integer N1 and N2 values while keeping N2/N1 as close as possible to the requested ratio and retaining the target-power requirement.

Dropout Adjustment

If a dropout rate is specified, the required evaluable group sizes are inflated using N1′ = N1/(1 - DR) and N2′ = N2/(1 - DR), with each enrollment size rounded up, consistent with the relevant methodological literature.

Assumptions and Interpretation

This calculator is intended for two independent groups with continuous responses and no ties, matching the assumptions of the this method Noether procedure. The Mann-Whitney effect size P1 is a probability-based measure of separation between the two distributions; it is not automatically the same thing as a difference in means or medians unless additional location-shift assumptions are appropriate.

References

Noether, G. E. (1987). Sample size determination for some common nonparametric tests. Journal of the American Statistical Association, 82(398), 645–647.

Lehmann, E. L. (1975). Nonparametrics: Statistical Methods Based on Ranks. Holden-Day.

Zhao, Y. D., Rahardja, D., & Qu, Y. (2008). Sample size calculation for the Wilcoxon-Mann-Whitney test adjusting for ties. Statistics in Medicine, 27, 462–468.

the software. this method Sample Size Software: Mann-Whitney U or Wilcoxon Rank-Sum Tests (Noether), Chapter 257.

Clinical Trials

Real trials behind this calculation

See the analysis this calculator plans for applied to published trial results, with the estimates, confidence intervals and interpretation explained.

RELAX-AHF-2
Independent statistical analysis of Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF: primary endpoint results, effect estimate…
Phase 3 · n = 6,600
DISCOVER
Independent statistical analysis of the DISCOVER phase 3 trial evaluating F/TAF versus F/TDF for HIV-1 pre-exposure prophylaxis, including non-inferiority testing, rate-ratio analysis,…
Phase 3 · n = 5,399
MANDALA
A detailed statistical analysis of the phase 3 MANDALA trial of budesonide/albuterol metered-dose inhalers versus albuterol in adults and children 4 years…
Phase 3 · n = 3,132
TRANSFORM-HF
Complete statistical analysis of TRANSFORM-HF, the randomized phase 3 comparison of torsemide versus furosemide for management of heart failure, including time-to-event, rehospitalization,…
Phase 3 · n = 2,973
RELAX-AHF-EU
Complete statistical analysis of RELAX-AHF-EU, a randomized phase 3 trial evaluating serelaxin plus standard of care versus standard of care in patients…
Phase 3 · n = 2,666
RELAX-AHF-EU
Independent statistical analysis of Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients: primary endpoint results, effect estimate…
Phase 3 · n = 2,666
See all 79 trials using Wilcoxon / Mann-Whitney test →
Clinical Biostats